alexa Bioconjugated (amino) Quercitol With Cinnamic Acid Derivatives: Synthesis, Bio-activity Assays And Kinetic Studies
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Eakkaphon Rattanangkool, Thanakorn Dumsud, Preecha Phuwapraisirisan and Sumrit Wacharasindhu
Posters: Med Chem
DOI: 10.4172/2161-0444.S1.012
Abstract
Bioconjugated compounds, containing two biomolecules directly connected together or by linker, have been developed to improve specific chemical property or biological activity. Common types of bioconjugation reactions are coupling of protein, lipid, amino acid or sugar. In this research, we have focused on synthesis of bioconjugated compounds containing cinnamic acid derivatives (CADs) and (+)-proto-quercitol through amide or ester linkage. CADs have been documented to possess antioxidant and α-glucosidase inhibitory effect, and quercitol is a sugar mimic. We hope that the combination of two active moieties would afford bioconjugates with improved activities. In this research, 31 novel (quercityl-cinnamate derivatives and quercityl-cinnamamide derivatives) were prepared from trans-cinnamic acid derivatives and natural carbasugars, (+)-protoquercitol which is isolated from the stems of Arfeuillea arborescens. All synthesized compounds are fully characterized and investigated for their α-glucosidase inhibitory effect against baker?s yeast and rat intestine (maltase and sucrase) in vitro. Most compounds potentially inhibit α-glucosidase from rat intestine with IC50 value in the range of 0.41-527.41 μM, which are 1.4-208 times greater than that of starting cinnamic acid derivatives. Of the prepared compounds, 11AS inhibited maltase with an IC50 value of 0.41 μM, which had potency similar to antidiabetic drug, acarbose and voglibose (IC50=1.5 and 0.25 μM). While its radical scavenging (SC50=0.07 mM) were comparable to that of commercial antioxidant BHA (SC50=0.10 mM), but (amino)quercitols, acarbose and voglibose were not effected on DPPH scavenging. In addition, an investigation on mechanism underlying inhibitory effect of 11AS indicated that it blocked maltase functions by noncompetitive manner. For synergistic effect of 11AS, inhibitory activity against maltase exerted by a mixture of acarbose and 11AS significantly improved (8 to 42%), compare with acarbose alone, suggesting that they may provide a significant clinical benefit in delaying postprandial hyperglycemia.
Biography
Eakkaphon Rattaangkool has been studying in Natural Product Chemistry and Organic Synthetic Methodology Chemistry field from Chulalongkorn University. His research focused on the synthesis of cinnamic acid derivatives/quercitol bioconjugates as antioxidant and a-glucosidase inhibitor at Department of Chemistry, Faculty of Science, Chulalongkorn University. He has published 4 papers in scientific journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords